CVRx, Inc. (CVRX)
0.55
+0.02
(+3.21%)
USD |
NASDAQ |
Nov 20, 11:18
CVRx Cash from Investing (Quarterly) : -0.098M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.098M |
| June 30, 2026 | -0.112M |
| March 31, 2026 | -0.122M |
| December 31, 2025 | -0.068M |
| September 30, 2025 | -0.295M |
| June 30, 2025 | -0.103M |
| March 31, 2025 | -0.114M |
| December 31, 2024 | -0.052M |
| September 30, 2024 | -0.037M |
| June 30, 2024 | -0.355M |
| March 31, 2024 | -0.917M |
| December 31, 2023 | -0.169M |
| September 30, 2023 | -0.039M |
| June 30, 2023 | -0.143M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.24M |
| December 31, 2022 | -0.079M |
| September 30, 2022 | -0.264M |
| June 30, 2022 | -0.049M |
| March 31, 2022 | -0.293M |
| December 31, 2021 | -0.538M |
| September 30, 2021 | -0.165M |
| June 30, 2021 | -0.379M |
| March 31, 2021 | -0.101M |
| December 31, 2020 | -0.101M |
| September 30, 2020 | -0.118M |
| June 30, 2020 | -0.043M |
| March 31, 2020 | -0.049M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Stereotaxis, Inc. | -2.952M |
| Accuray, Inc. | -5.004M |
| Orthofix Medical, Inc. | -14.24M |
| ResMed, Inc. | 392.06M |
| Rockwell Medical, Inc. | 1.756M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.90M |
| Cash from Financing (Quarterly) | 5.155M |
| Free Cash Flow | -42.04M |
| Free Cash Flow Per Share (Quarterly) | -0.4035 |
| Free Cash Flow to Equity (Quarterly) | -10.99M |
| Free Cash Flow to Firm (Quarterly) | -9.388M |
| Free Cash Flow Yield | -268.4% |